Insomnia is prevalent in pediatrics, particularly in those with 
neurodevelopmental disorders. Gabapentin has shown promise in treating insomnia 
in adults. The purpose of our study was to review our experience with using 
gabapentin to treat insomnia in children. We identified 23 children, seen by the 
authors in our Pediatric Sleep Clinic from January 2009 to March 2012. The mean 
age was 7.2 years and 70% were male. The majority (87%) had been given diagnoses 
of neurodevelopmental or neuropsychiatric disorders. All parents received 
education in sleep behavioral interventions. The majority of children (70%) had 
both sleep-onset and sleep maintenance insomnia. The average starting dose of 
gabapentin was 5 mg/kg every bedtime and the maximal dose was 15 mg/kg every 
bedtime. At follow-up, improved sleep was noted in 78% of children. Adverse 
effects were noted in 6 children.